Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel

Perspective > Medscape Ob/Gyn > Kaunitz on Women's Health

COMMENTARY

Why I'm Offering DMPA to Patients With Uterine Fibroids

Andrew M. Kaunitz, MD

Disclosures

May 20, 2022

Download Slides

To continue reading this article ...

Continue reading your article with a Medscape account

Join the Top Medical Resource for Physicians Today. Free Membership!

Recommendations

2001/viewarticle/973296
Why I'm Offering DMPA to Patients With Uterine Fibroids
2001/viewarticle/973813
Relugolix Combo Eases Long-Neglected Fibroid Symptom: Pain
2003/viewarticle/953137
Uterine Fibroid Treatment: The Role of GnRH Receptor Antagonists in Long-Term Medical Management 0.5 CME / ABIM MOC Credits Clinical Review

You are being redirected to Medscape Education
Yes, take me there

0.5 CME / ABIM MOC

Uterine Fibroid Treatment: The Role of GnRH Receptor Antagonists in Long-Term Medical Management
2001/viewarticle/965129
EMA Panel Backs Linzagolix for Uterine Fibroid Symptoms

Tables

Authors and Disclosures

Author(s)

Andrew M. Kaunitz, MD

Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine – Jacksonville, Jacksonville, Florida

Disclosure: Andrew M. Kaunitz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: AMAG Pharmaceuticals, Inc; Merck & Co, Inc; Mithra; Pfizer, Inc
Receives research grants (funds paid to University of Florida) from: Allergan, Inc; Bayer HealthCare Pharmaceuticals; Endoceutics; Evafem; Mithra; Myovant; Medicines360
Serve(d) on the Safety Monitoring Board for: Femasys
Received royalties from: UpToDate

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

Why I'm Offering DMPA to Patients With Uterine Fibroids

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Andrew M. Kaunitz, MD

Comments

Most Popular Articles

Email This

Feedback